Navigation Links
AcelRx Pharmaceuticals Provides Clinical Trial Updates
Date:2/19/2013

REDWOOD CITY, Calif., Feb. 19, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced continuing progress on its two remaining Phase 3 trials of the Sufentanil NanoTab PCA System being studied in post-operative pain.  The first of those studies in patients after major abdominal surgery completed the last patient earlier this quarter, and is expected to provide data later this quarter.  The second study, in patients after major orthopedic surgery, continues to enroll patients, with the last patient expected to enroll around the end of the first quarter of 2013, and data expected in the second quarter.  A New Drug Application (NDA) submission for the NanoTab System remains on track for the third quarter of 2013.  In addition, a Phase 2 clinical trial with ARX-04, a sufentanil formulation for the treatment of moderate-to-severe acute pain, has completed dosing and results from this study are expected to be available in the second quarter of 2013.

"We look forward to sharing the top-line results from our abdominal surgery pain study with our lead product candidate, the Sufentanil NanoTab PCA System, later this quarter and remain on track for an NDA submission later this year," said Richard King , president and chief executive officer of AcelRx.    

Status of Ongoing Clinical Trials

  • The last patient has completed the Sufentanil NanoTab PCA System Phase 3 double-blind, placebo-controlled post-operative pain study conducted in patients following open abdominal surgery.  The study, initiated in March 2012, enrolled 178 patients at 14 sites. T
    '/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
2. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
3. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
4. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
5. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
8. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
9. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
10. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
11. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... , July 25, 2014  Corporate libraries are ... understanding new advancements in technology and how to cope ... libraries in the pharmaceutical and medical device industries are ... the information and services they provide. ... LLC there are many forces of change that leading ...
(Date:7/25/2014)... , July 25, 2014  In today,s marketplace, ... costly and challenging - as is managing a portfolio ... Is it possible - or even preferable - ... so, where can you combine resources and activities, and ... These are just a few of the ...
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy ... on the Australia Capsule Endoscopy Systems market. The report ... units) and average prices (in US dollars) within market ... , Capsule Endoscopes , Capsule Endoscopy ... The report also provides company shares and distribution ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... Abbott (NYSE: ABT ) has completed its ... and oncology. , , ... The acquisition provides Abbott with a promising biologic intended to treat ... program.  The new Abbott compounds include daclizumab – a Phase II ...
... , , ... ... , , ... ...
Cached Medicine Technology:Abbott Completes Acquisition of Facet Biotech 2World TB Day Senate Briefing 2World TB Day Senate Briefing 3World TB Day Senate Briefing 4World TB Day Senate Briefing 5
(Date:7/25/2014)... Dental Perfection, a Derby cosmetic dentist ... general dentistry, clear braces and much more, has just ... in Derby. The new practice, which is scheduled to ... in Littleover, Derby. Patients may already pre-register for the ... dental practice, which is headed by Invisalign specialist and ...
(Date:7/25/2014)... Dublin, Ireland (PRWEB) July 26, 2014 ... high quality legal help to people who have ... announced the launch of both their new company, ... an article on the new website explained, ... injury law. The focus of the company is ...
(Date:7/25/2014)... 26, 2014 2014 Deep ... Permeation Chromatography Industry” is a professional and ... China Gel Permeation Chromatography market. The report ... Gel Permeation Chromatography definition, classification, application, and ... overview. This research covers the international market ...
(Date:7/25/2014)... 2014 2014 Deep Research Report ... Industry” is a professional and in-depth research ... market. The report provides basic Laser Scanning ... Microscope definition, classification, application, and industry chain ... covers international market analysis, including China’s domestic market ...
(Date:7/25/2014)... In recent years, men have become more ... the symptoms associated with age-related testosterone decline. Amid concerns about ... new case study from Renew Man helps to ... using bioidentical hormones. , The case study centers around ... found himself beginning to feel the effects of age-related hormonal ...
Breaking Medicine News(10 mins):Health News:Derby Cosmetic Dentist Dental Perfection to Open New Practice in Littleover, Derby this September 2Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3
... connected to more cognitive problems during a person’s old ... A higher risk factor// is encountered by people who ... cognitive functions are concerned. As many as 60% of ... affected by hypertension. , ,However, this ‘silent ...
... of organs from executed prisoners being sold to foreigners ... controversy and confusion. Chinese health officials, who have been ... admitted about the widespread prevalence of such an inhuman ... of grafts transplanted from total strangers (were paid for ...
... of brain enlargement has been discovered by magnetic resonance ... from autism, when in comparison to other normal children, ... ,Abnormalities in communication, repetitive and stereotyped behaviors, and social ... neuroanatomical basis for this condition is yet to discovered. ...
... to give up smoking on a voluntary basis. If this healthy ... the Government// that hopes to impose a public ban on smoking ... up the smoking help line has infact increased by a margin ... promising compared to the figures in 2003 where merely 40,000 members ...
... exercise can keep Alzheimer’s disease at bay according to a ... out the toxic chemical that causes this degenerative disease of ... the toxic molecules with beneficial ones that protect the nerve ... the Cajal Institute in Madrid, found that exercise doubles the ...
... London: For the first time in 90 years the timings ... the traditional 11PM to round the clock drinking. ,Thousands of ... an extra drink in pubs and bars after midnight. ... opening hours, already a feature in most European countries, have ...
Cached Medicine News:Health News:Blood Pressure Later Leads to Cognitive Problems 2Health News:Widespread Commercialisation Of Human Organ Donation In China 2Health News:Exercise keeps ‘Alzheimer’s Awa 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: